CO6351782A2 - COMPUESTOS NOVEDOSOS CON ACTIVIDAD ANTAGONISTA DEL RECEPTOR á 7 NICOTINICO DE ACETILCOLINA - Google Patents
COMPUESTOS NOVEDOSOS CON ACTIVIDAD ANTAGONISTA DEL RECEPTOR á 7 NICOTINICO DE ACETILCOLINAInfo
- Publication number
- CO6351782A2 CO6351782A2 CO09070527A CO09070527A CO6351782A2 CO 6351782 A2 CO6351782 A2 CO 6351782A2 CO 09070527 A CO09070527 A CO 09070527A CO 09070527 A CO09070527 A CO 09070527A CO 6351782 A2 CO6351782 A2 CO 6351782A2
- Authority
- CO
- Colombia
- Prior art keywords
- nicotinico
- acetilcolina
- new compounds
- antagonist activity
- receiver antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
- C07D231/40—Acylated on said nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
Abstract
La presente invención provee compuestos y composiciones, métodos para su fabricación y métodos para su uso a fin de modular los receptores nicotínicos de acetilcolina a7 y/o para el tratamiento de cualquiera de los diversos trastornos, enfermedad y factores. Los compuestos provistos pueden afectar, entre otras cosas, al sistema neurológico, psiquiátrico y/o inflamatorio.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88062907P | 2007-01-16 | 2007-01-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6351782A2 true CO6351782A2 (es) | 2011-12-20 |
Family
ID=39345157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09070527A CO6351782A2 (es) | 2007-01-16 | 2009-07-08 | COMPUESTOS NOVEDOSOS CON ACTIVIDAD ANTAGONISTA DEL RECEPTOR á 7 NICOTINICO DE ACETILCOLINA |
Country Status (25)
Country | Link |
---|---|
US (1) | US8163729B2 (es) |
EP (1) | EP2118067B1 (es) |
JP (1) | JP2010515770A (es) |
KR (1) | KR20090116707A (es) |
CN (1) | CN101679287B (es) |
AR (1) | AR064921A1 (es) |
AU (1) | AU2008206759B2 (es) |
BR (1) | BRPI0806665A2 (es) |
CA (1) | CA2675676A1 (es) |
CL (1) | CL2008000119A1 (es) |
CO (1) | CO6351782A2 (es) |
CR (1) | CR10930A (es) |
EA (1) | EA016948B1 (es) |
EC (1) | ECSP099490A (es) |
HK (1) | HK1142335A1 (es) |
IL (1) | IL199889A0 (es) |
MX (1) | MX2009007615A (es) |
NZ (1) | NZ578411A (es) |
PA (1) | PA8766201A1 (es) |
SA (1) | SA08290018B1 (es) |
SV (1) | SV2009003334A (es) |
TW (1) | TW200901974A (es) |
UA (1) | UA98317C2 (es) |
WO (1) | WO2008087529A1 (es) |
ZA (1) | ZA200904943B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200901974A (en) | 2007-01-16 | 2009-01-16 | Wyeth Corp | Compounds, compositions, and methods of making and using them |
WO2009091831A1 (en) * | 2008-01-14 | 2009-07-23 | Wyeth | Compound forms and uses thereof |
WO2009091813A1 (en) * | 2008-01-14 | 2009-07-23 | Wyeth | Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
US20090264648A1 (en) * | 2008-01-14 | 2009-10-22 | Wyeth | Synthesis of pyrazoles |
TW201004941A (en) * | 2008-07-16 | 2010-02-01 | Wyeth Corp | Alpha7 nicotinic acetylcholine receptor inhibitors |
DK2328619T3 (en) | 2008-08-22 | 2017-03-13 | Baxalta GmbH | POLYMER BENZYL CARBONATE DERIVATES |
US8865719B2 (en) * | 2009-03-09 | 2014-10-21 | The Regents Of The University Of California | Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors |
CN102573842A (zh) * | 2009-07-23 | 2012-07-11 | 诺瓦提斯公司 | 氮杂双环烷基衍生物或吡咯烷-2-酮衍生物的用途 |
JO3250B1 (ar) | 2009-09-22 | 2018-09-16 | Novartis Ag | إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7 |
CN103619171B (zh) * | 2010-11-03 | 2015-11-25 | 陶氏益农公司 | 杀虫组合物和与其相关的方法 |
CA2813451A1 (en) * | 2010-11-18 | 2012-05-24 | Dignity Health | Methods of diagnosing and treating neurodegenerative diseases |
US20150259344A1 (en) * | 2012-10-02 | 2015-09-17 | Dainippon Sumitomo Pharma Co., Ltd. | Imidazole derivative |
CN105254564A (zh) * | 2015-10-31 | 2016-01-20 | 丁玉琴 | 一种2-甲基-3,4-二硝基-5-(甲氧苯基)吡唑的合成方法 |
CN105646358B (zh) * | 2016-03-01 | 2018-03-09 | 苏州艾缇克药物化学有限公司 | 一种3‑氨基‑5‑(4‑甲氧苯基)吡唑的合成方法 |
CN112480079B (zh) * | 2017-11-08 | 2022-03-11 | 北京嘉林药业股份有限公司 | 化合物及其治疗癌症的用途 |
TWI805699B (zh) | 2018-03-01 | 2023-06-21 | 日商日本煙草產業股份有限公司 | 甲基內醯胺環化合物及其用途 |
JP7130588B2 (ja) | 2018-04-04 | 2022-09-05 | 日本たばこ産業株式会社 | ヘテロアリールで置換されたピラゾール化合物及びその医薬用途 |
GB202006382D0 (en) | 2020-04-30 | 2020-06-17 | Spermatech As | Use |
CN113925606B (zh) * | 2021-10-25 | 2023-07-07 | 四川大学华西医院 | 一种神经调控导航定位方法、装置和神经调控治疗系统 |
Family Cites Families (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU167263B (es) | 1973-02-12 | 1975-09-27 | ||
DE2527677A1 (de) * | 1975-06-21 | 1977-01-20 | Bayer Ag | Verfahren zur herstellung von 2,4- dioxo-1,2,3,4-tetrahydro-s-triazino- eckige klammer auf 1,2-a eckige klammer zu -benzimidazolen |
US4665183A (en) * | 1985-12-20 | 1987-05-12 | American Home Products Corp. | Process for preparing 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof useful for the treatment of cognitive impairments |
US4624954A (en) * | 1985-12-20 | 1986-11-25 | American Home Products Corporation | 6,7,8,9-tetrahydro-10-methylpyrido[1,2-a]indol-9-amines and derivatives thereof, useful for the treatment of cognitive impairments |
US5219857A (en) * | 1986-10-16 | 1993-06-15 | American Cyanamid Company | Method of treating cognitive and related neural behavioral problems |
US4904658A (en) * | 1988-04-15 | 1990-02-27 | American Cyanamid Company | Substituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and substituted-6H,10H-pyrimido[1,2-cd]purin-10-ones |
US5260331A (en) | 1989-01-02 | 1993-11-09 | John Wyeth & Brother Limited | Composition for treating depression with (S- or O-heteroaryl)alkyl amines |
US5422355A (en) * | 1989-06-02 | 1995-06-06 | John Wyeth & Brother, Limited | Composition for treating depression with (N-heteroaryl)alkylamines |
FR2655988B1 (fr) | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
IE911774A1 (en) | 1990-06-11 | 1991-12-18 | Akzo Nv | Pyridinylpiperazine derivatives |
AU645681B2 (en) | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
GB9125615D0 (en) | 1991-12-02 | 1992-01-29 | Wyeth John & Brother Ltd | Amines |
CA2126976A1 (en) | 1991-12-31 | 1993-07-08 | Hisashi Takasugi | Oxadiazole derivatives having acetylcholinesterase-inhibitory and muscarinic agonist activity |
JPH0616638A (ja) | 1992-03-30 | 1994-01-25 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物およびその医薬用途 |
DE69331761T2 (de) | 1992-07-24 | 2002-09-12 | Univ California | Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen |
RU2130453C1 (ru) | 1992-12-17 | 1999-05-20 | Пфайзер Инк. | Замещенные пиразолы, фармацевтическая композиция на их основе, способ лечения, промежуточный продукт |
TW370529B (en) | 1992-12-17 | 1999-09-21 | Pfizer | Pyrazolopyrimidines |
EP0674641B1 (en) | 1992-12-17 | 1999-03-03 | Pfizer Inc. | Pyrrolopyrimidines as crf antagonists |
TW336932B (en) | 1992-12-17 | 1998-07-21 | Pfizer | Amino-substituted pyrazoles |
CA2150483C (en) | 1992-12-17 | 1999-09-14 | Pfizer Limited | Pyrazoles and pyrazolopyrimidines |
GB9302622D0 (en) | 1993-02-10 | 1993-03-24 | Wellcome Found | Heteroaromatic compounds |
DE69521745T2 (de) | 1994-01-14 | 2002-05-23 | Azwell Inc | Diazacycloalkanalkylsulfonamid-derivat |
JP3319651B2 (ja) * | 1994-04-26 | 2002-09-03 | 富士写真フイルム株式会社 | 感光性転写シート |
US5650409A (en) | 1995-06-02 | 1997-07-22 | Cortex Pharmaceuticals, Inc. | Benzoyl piperidines/pyrrolidines for enhancing synaptic response |
GB9514901D0 (en) | 1995-07-20 | 1995-09-20 | American Home Prod | Piperazine derivatives |
US6288091B1 (en) * | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
SE9600683D0 (sv) | 1996-02-23 | 1996-02-23 | Astra Ab | Azabicyclic esters of carbamic acids useful in therapy |
US5736543A (en) | 1996-04-03 | 1998-04-07 | The Regents Of The University Of California | Benzoxazines for enhancing synaptic response |
CZ363298A3 (cs) | 1996-05-11 | 1999-06-16 | Smithkline Beecham P. L. C. | Tetrahydroizochinolinové deriváty jako modulátory receptorů dopaminu D3 |
GB9708694D0 (en) | 1997-04-30 | 1997-06-18 | Smithkline Beecham Plc | Compounds |
GB9708805D0 (en) | 1997-05-01 | 1997-06-25 | Smithkline Beecham Plc | Compounds |
US6329368B1 (en) | 1997-05-09 | 2001-12-11 | The Regents Of The University Of California | Endocrine modulation with positive modulators of AMPA type glutamate receptors |
KR100247563B1 (ko) | 1997-07-16 | 2000-04-01 | 박영구 | 키랄3,4-에폭시부티르산및이의염의제조방법 |
ATE252575T1 (de) * | 1997-07-25 | 2003-11-15 | Lundbeck & Co As H | Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung |
US6632823B1 (en) | 1997-12-22 | 2003-10-14 | Merck & Co., Inc. | Substituted pyridine compounds useful as modulators of acetylcholine receptors |
CA2320354A1 (en) | 1998-02-18 | 1999-08-26 | Neurosearch A/S | Novel compounds and their use as positive ampa receptor modulators |
NZ525108A (en) | 1998-03-31 | 2005-02-25 | Acadia Pharm Inc | Compounds with activity on muscarinic receptors |
US6124278A (en) | 1998-04-03 | 2000-09-26 | The Regents Of The University Of California | Acylbenzoxazines for enhancing synaptic response |
DE69913520T2 (de) | 1998-06-01 | 2004-11-25 | Ortho-Mcneil Pharmaceutical, Inc. | Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten |
US6605623B1 (en) | 1998-12-18 | 2003-08-12 | Bristol-Myers Squibb Pharma Co. | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
US6313126B1 (en) * | 1999-01-07 | 2001-11-06 | American Home Products Corp | Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
SE9900100D0 (sv) | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
US6677333B1 (en) * | 1999-01-26 | 2004-01-13 | Ono Pharmaceutical Co., Ltd. | 2H-phthalazin-1-one derivatives and drug containing its derivatives as active ingredient |
US20010044445A1 (en) * | 1999-04-08 | 2001-11-22 | Bamaung Nwe Y. | Azole inhibitors of cytokine production |
US6387900B1 (en) | 1999-08-12 | 2002-05-14 | Pharmacia & Upjohn S.P.A. | 3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents |
JP2003513064A (ja) | 1999-11-05 | 2003-04-08 | ユニバーシティ カレッジ ロンドン | 可溶性グアニル酸シクラーゼのアクチベーター |
SE9904176D0 (sv) | 1999-11-18 | 1999-11-18 | Astra Ab | New use |
US7091227B2 (en) * | 2000-02-07 | 2006-08-15 | Abbott Gmbh & Co. Kg | Benzothiazole derivatives |
EP1268421B1 (en) | 2000-03-31 | 2009-05-06 | Ortho-McNeil Pharmaceutical, Inc. | Phenyl-substituted indoles as histamine h3-receptor antagonists |
ATE361297T1 (de) | 2000-03-31 | 2007-05-15 | Ortho Mcneil Pharm Inc | Phenyl-substituierte imidazopyridine |
HUP0300413A2 (hu) | 2000-04-10 | 2003-06-28 | Pfizer Products Inc. | Amidcsoportot viselő benzolgyűrűs csoporttal helyettesített piperidint tartalmazó és rokonszerkezetű vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
US6448276B1 (en) * | 2000-05-17 | 2002-09-10 | Inspire Pharmaceuticals, Inc. | Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists |
JP2004516237A (ja) | 2000-06-21 | 2004-06-03 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | ケモカイン受容体活性調節剤としてのピペリジンアミド類 |
JP2002030073A (ja) | 2000-07-19 | 2002-01-29 | Ono Pharmaceut Co Ltd | 4−(3−(4−モルホリノブチリルアミノ)フェニル)−2h−フタラジン−1−オン・メタンスルホン酸塩・1水和物およびその製造方法。 |
US7211594B2 (en) * | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
US20020173507A1 (en) | 2000-08-15 | 2002-11-21 | Vincent Santora | Urea compounds and methods of uses |
IL145209A0 (en) | 2000-09-06 | 2002-06-30 | Pfizer Prod Inc | Pharmaceutical combinations for the treatment of stroke and traumatic brain injury |
US7109199B2 (en) | 2000-09-22 | 2006-09-19 | Smithkline Beecham Corporation | Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
US6469007B2 (en) | 2000-11-28 | 2002-10-22 | Wyeth | Serotonergic agents |
IL156268A0 (en) | 2000-12-13 | 2004-01-04 | Wyeth Corp | Heterocyclic sulfonamide inhibitors of beta amyloid production |
UA73619C2 (en) | 2000-12-13 | 2005-08-15 | Pfizer Prod Inc | Stable pharmaceutical compositions of nmda receptor agonist (variants) and method of treatment |
IL157363A0 (en) | 2001-02-16 | 2004-02-19 | Aventis Pharma Inc | Novel heterocyclic urea derivatives and their use as dopamine d3 receptor ligands |
WO2002066446A1 (en) | 2001-02-16 | 2002-08-29 | Aventis Pharmaceuticals Inc. | Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands |
HUP0103986A2 (hu) | 2001-09-28 | 2003-06-28 | Richter Gedeon Vegyészeti Gyár Rt. | Új karbonsavamid szerkezetet tartalmazó piperidinil vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
HUP0103987A3 (en) | 2001-09-28 | 2004-11-29 | Richter Gedeon Vegyeszet | Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates |
KR100579813B1 (ko) | 2001-10-16 | 2006-05-12 | 주식회사 에스티씨나라 | 피페리딘 유도체, 이의 제조방법 및 이를 포함하는 치매치료용 약학적 조성물 |
CN100348587C (zh) | 2002-02-19 | 2007-11-14 | 小野药品工业株式会社 | 稠合哒嗪衍生物化合物和含这些化合物作为活性成份的药物 |
DE10211415A1 (de) | 2002-03-15 | 2003-09-25 | Bayer Ag | Bicyclische N-Biarylamide |
UA78999C2 (en) * | 2002-06-04 | 2007-05-10 | Wyeth Corp | 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6 |
UA77814C2 (en) | 2002-07-03 | 2007-01-15 | Lundbeck & Co As H | Spirocyclic piperidines as antagonists of mch1 and use thereof |
GB0216233D0 (en) | 2002-07-12 | 2002-08-21 | Glaxo Group Ltd | Compounds |
US7183411B2 (en) * | 2002-07-12 | 2007-02-27 | Janssen Pharmaceutica N.V. | Naphthol, quinoline and isoquinoline-derived urea modulators of vanilloid VR1 receptor |
TW200401641A (en) * | 2002-07-18 | 2004-02-01 | Wyeth Corp | 1-Heterocyclylalkyl-3-sulfonylindole or-indazole derivatives as 5-hydroxytryptamine-6 ligands |
US7176198B2 (en) | 2002-08-01 | 2007-02-13 | Pfizer Inc. | 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
AU2003269413A1 (en) | 2002-11-01 | 2004-05-25 | Pharmacia & Upjohn Company Llc | Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy |
US7186832B2 (en) * | 2003-02-20 | 2007-03-06 | Sugen Inc. | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
US7157460B2 (en) * | 2003-02-20 | 2007-01-02 | Sugen Inc. | Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
TWI334868B (en) * | 2003-06-03 | 2010-12-21 | Nippon Kayaku Kk | [1,2,4] triazoro [1,5-a] pyrimidine-2-ylurea derivative and use thereof |
DK1648904T3 (da) * | 2003-07-31 | 2007-10-22 | Wyeth Corp | N-sulfonylheterocyclopyrrolalkylaminforbindelser som 5-hydroxytryptamin-6-ligander |
US7572914B2 (en) | 2003-12-19 | 2009-08-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
DE602005015682D1 (de) | 2004-02-04 | 2009-09-10 | Neurosearch As | Dimere azacyclische verbindungen und deren verwendung |
EP1720886A1 (en) * | 2004-03-02 | 2006-11-15 | Wyeth | Macrolides and methods for producing same |
US20050197356A1 (en) | 2004-03-02 | 2005-09-08 | Wyeth | Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents |
JP2008503460A (ja) * | 2004-06-16 | 2008-02-07 | ワイス | β−セクレターゼのインヒビターとしてのジフェニルイミダゾピリミジンおよびイミダゾールアミン |
TW200602045A (en) * | 2004-06-16 | 2006-01-16 | Wyeth Corp | Amino-5, 5-diphenylimidazolone derivatives for the inhibition of β-secretase |
BRPI0511993A (pt) * | 2004-07-20 | 2008-01-22 | Siena Biotech Spa | compostos moduladores de receptores de acetilcolina nicotìnicos alfa7, composições farmacêuticas e usos terapêuticos dos mesmos |
US20060063930A1 (en) | 2004-08-20 | 2006-03-23 | Agoston Gregory E | Compositions and methods comprising proteinase activated receptor antagonists |
WO2006077428A1 (en) | 2005-01-21 | 2006-07-27 | Astex Therapeutics Limited | Pharmaceutical compounds |
JP2008531596A (ja) | 2005-02-25 | 2008-08-14 | ライジェル ファーマシューティカルズ, インコーポレイテッド | Hcv感染を治療または予防するのに有用なベンゾイソチアゾール |
EP1949102A2 (en) * | 2005-11-15 | 2008-07-30 | Inverness Medical Switzerland GmbH | Assays |
CA2637530A1 (en) * | 2006-01-18 | 2007-09-07 | Siena Biotech S.P.A. | Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
TW200901974A (en) | 2007-01-16 | 2009-01-16 | Wyeth Corp | Compounds, compositions, and methods of making and using them |
GB0723815D0 (en) | 2007-12-05 | 2008-01-16 | Glaxo Group Ltd | Compounds |
WO2009091813A1 (en) | 2008-01-14 | 2009-07-23 | Wyeth | Compounds useful as alpha7 nicotinic acetylcholine receptor agonists |
WO2009091831A1 (en) | 2008-01-14 | 2009-07-23 | Wyeth | Compound forms and uses thereof |
US20090264648A1 (en) * | 2008-01-14 | 2009-10-22 | Wyeth | Synthesis of pyrazoles |
TW201004941A (en) * | 2008-07-16 | 2010-02-01 | Wyeth Corp | Alpha7 nicotinic acetylcholine receptor inhibitors |
US20100016360A1 (en) * | 2008-07-16 | 2010-01-21 | Wyeth | Alpha7 nicotinic acetylcholine receptor inhibitors |
US20100016343A1 (en) * | 2008-07-16 | 2010-01-21 | Wyeth | Alpha7 nicotinic acetylcholine receptor inhibitors |
US20100016598A1 (en) * | 2008-07-16 | 2010-01-21 | Wyeth | Alpha7 nicotinic acetylcholine receptor inhibitors |
-
2008
- 2008-01-15 TW TW097101453A patent/TW200901974A/zh unknown
- 2008-01-15 CL CL200800119A patent/CL2008000119A1/es unknown
- 2008-01-16 BR BRPI0806665-5A patent/BRPI0806665A2/pt not_active IP Right Cessation
- 2008-01-16 JP JP2009546013A patent/JP2010515770A/ja active Pending
- 2008-01-16 SA SA08290018A patent/SA08290018B1/ar unknown
- 2008-01-16 CN CN200880008464XA patent/CN101679287B/zh not_active Expired - Fee Related
- 2008-01-16 EA EA200900831A patent/EA016948B1/ru not_active IP Right Cessation
- 2008-01-16 KR KR1020097014828A patent/KR20090116707A/ko not_active Application Discontinuation
- 2008-01-16 US US12/523,189 patent/US8163729B2/en not_active Expired - Fee Related
- 2008-01-16 UA UAA200907422A patent/UA98317C2/ru unknown
- 2008-01-16 WO PCT/IB2008/000090 patent/WO2008087529A1/en active Application Filing
- 2008-01-16 AR ARP080100189A patent/AR064921A1/es not_active Application Discontinuation
- 2008-01-16 MX MX2009007615A patent/MX2009007615A/es active IP Right Grant
- 2008-01-16 CA CA002675676A patent/CA2675676A1/en not_active Abandoned
- 2008-01-16 NZ NZ578411A patent/NZ578411A/en not_active IP Right Cessation
- 2008-01-16 ZA ZA200904943A patent/ZA200904943B/xx unknown
- 2008-01-16 PA PA20088766201A patent/PA8766201A1/es unknown
- 2008-01-16 EP EP08702252.1A patent/EP2118067B1/en active Active
- 2008-01-16 AU AU2008206759A patent/AU2008206759B2/en not_active Ceased
-
2009
- 2009-07-03 EC EC2009009490A patent/ECSP099490A/es unknown
- 2009-07-08 CO CO09070527A patent/CO6351782A2/es not_active Application Discontinuation
- 2009-07-15 SV SV2009003334A patent/SV2009003334A/es unknown
- 2009-07-15 CR CR10930A patent/CR10930A/es unknown
- 2009-07-16 IL IL199889A patent/IL199889A0/en unknown
-
2010
- 2010-09-20 HK HK10108947.5A patent/HK1142335A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US8163729B2 (en) | 2012-04-24 |
EP2118067B1 (en) | 2013-05-08 |
NZ578411A (en) | 2011-06-30 |
UA98317C2 (ru) | 2012-05-10 |
CA2675676A1 (en) | 2008-07-24 |
CL2008000119A1 (es) | 2008-05-16 |
TW200901974A (en) | 2009-01-16 |
PA8766201A1 (es) | 2008-11-19 |
KR20090116707A (ko) | 2009-11-11 |
AU2008206759B2 (en) | 2013-09-05 |
AU2008206759A1 (en) | 2008-07-24 |
HK1142335A1 (en) | 2010-12-03 |
CN101679287B (zh) | 2013-03-27 |
JP2010515770A (ja) | 2010-05-13 |
WO2008087529A1 (en) | 2008-07-24 |
CN101679287A (zh) | 2010-03-24 |
AR064921A1 (es) | 2009-05-06 |
IL199889A0 (en) | 2010-04-15 |
CR10930A (es) | 2013-02-12 |
SV2009003334A (es) | 2010-08-09 |
ECSP099490A (es) | 2009-09-29 |
ZA200904943B (en) | 2010-09-29 |
BRPI0806665A2 (pt) | 2011-09-06 |
EA200900831A1 (ru) | 2010-02-26 |
MX2009007615A (es) | 2009-07-27 |
EA016948B1 (ru) | 2012-08-30 |
SA08290018B1 (ar) | 2013-01-17 |
EP2118067A1 (en) | 2009-11-18 |
US20100029606A1 (en) | 2010-02-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6351782A2 (es) | COMPUESTOS NOVEDOSOS CON ACTIVIDAD ANTAGONISTA DEL RECEPTOR á 7 NICOTINICO DE ACETILCOLINA | |
ECSP10010390A (es) | Compuestos | |
SV2005002061A (es) | Derivados de piridilo y su uso como antagonistas del receptor mglu5 ref. x-16538 | |
ECSP12012326A (es) | Derivados de aminopirimidina como moduladores de la lrrk2 | |
CL2012003604A1 (es) | Compuestos heterociclicos derivados de piridina carboxamida sustituida; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; uso en el tratamiento de trastornos proliferativos celulares, enfermedad de parkinson, cancer, entre otros. | |
IL210071A0 (en) | Triazolo [4,5-d]pyramidine derivatives and their use as purine receptor antagonists | |
UY31127A1 (es) | Ligandos de oxiadazol del receptor metabotropico para el glutamato y su utilizacion como potenciadores - 841 | |
ECSP067116A (es) | Antagonistas del receptor 2 de citocina quimioatrayente de sales cuaternarias | |
PA8795601A1 (es) | Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3 | |
GT200600081A (es) | Derivados de acetilenno | |
CL2009000697A1 (es) | Compuestos derivados de 2-heteroaril-6-fenil-imidazol [1,2-a]piridinas sustituidas; moduladores de receptores not; compuestos intermediarios; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de cancer, inflamacion, enfermedades neurodegenerativas, psiquiatricas, epilepsia, entre otras. | |
BR112012013431A2 (pt) | composto, composição farmacêutica e seu uso | |
CO6361994A2 (es) | Antagonistas del receptor de orexina de isonicotinamida | |
CO6300941A2 (es) | Compuestos de quinuclidina como ligandos del receptor nicotinico de acetilcolina alfa 7 | |
EA201071291A3 (ru) | Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств | |
CL2008001636A1 (es) | Compuestos derivados de bencimidazol, antagonistas de los receptores de angiotensina ii de tipo 1; proceso de preparacion de dichos compuestos; compuestos intermediarios; composicion farmaceutica de los compuestos; y su uso para tratar la hipertension, insuficiencia cardiaca. | |
CY1120403T1 (el) | Ανταγωνιστες trpm8 | |
CL2008001658A1 (es) | Composicion farmaceutica que comprende mesilato de imatinib amorfo y un principio de formulacion que estabiliza la forma amorfa; y su uso para tratar leucemia mieloide cronica avanzada y recientemente diagnosticada, leucemia mielomonocitica cronica, glioblastoma multiforme, entre otras. | |
ECSP099675A (es) | Compuestos heterocíclicos, composición y métodos de uso | |
PA8795701A1 (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de histamina-3 | |
ECSP11010956A (es) | Compuestos enlazados con azufre para el tratamiento de enfermedades y trastornos oftalmicos | |
ECSP088250A (es) | Derivados de pirazol como agentes terapéuticos | |
CL2011000832A1 (es) | Compuestos derivados de tieno[2,3-d]pirimidin-4-amina sustituidos, antagonista de los receptores de adenosina a2a; composicion farmaceutica; y su uso para tratar trastornos neurodegenerativos o motores, entre otras enfermedades. | |
ECSP088176A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de5-hidroxitriptamina-6 | |
PA8781601A1 (es) | " derivados de azaciclilbenzamida como antagonistas de histamina-3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |